Abstract
BackgroundRecently registry data provide evidence about long-term safety and efficacy of TNF inhibitors. However, data on Rituximab (RTX) treatment in daily clinical practice is limited.ObjectivesOur aim was to describe survival...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have